Evidence that hydrogen sulphide can modulate hypothalamo-pituitary-adrenal axis function: In vitro and in vivo studies in the rat

Journal of Neuroendocrinology

Volumn 12, Issue 3, 2000, Pages 225-233

  Dello Russo, C ^a   Tringali, G ^a   Ragazzoni, E ^a   Maggiano, N ^a   Menini, E ^a   Vairano, M ^a   Preziosi, P ^a   Navarra, P ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Corticosterone; Corticotropin releasing hormone; Hydrogen sulphide; S adenosyl methionine; Stress

Indexed keywords

AMINO ACID; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; HYDROGEN SULFIDE; METHIONINE; POTASSIUM CHLORIDE; SODIUM DITHIONITE;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CULTURE MEDIUM; HIPPOCAMPUS; HORMONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ADRENAL GLANDS; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; GLUCOCORTICOIDS; HYDROGEN SULFIDE; HYPOTHALAMUS; L-LACTATE DEHYDROGENASE; MALE; MICROSCOPY, ELECTRON; PITUITARY GLAND; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; S-ADENOSYLMETHIONINE; STRESS;

EID: 0034063304     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2000.00441.x     Document Type: Article

References (40)

1. Snyder SH, Jaffrey SR, Zakhary R. Nitric oxide and carbon monoxide: parallel roles as neural messengers. Brain Res Rev 1998; 26: 167-175.
2. Moncada S, Palmer RMJ, Higgs EO. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-141.
3. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. J Biol Chem 1984; 259: 9508-9513.
4. Erickson PF, Maxwell IH, Su L-J, Baumann M, Glode LM. Sequence of cDNA for rat cystathionine γ-lyase and comparison of deduced amino acid sequence with related Escherechia coli enzymes. Biochem J 1990; 269: 335-340.
5. Porter P, Grishaver MS, Jones OW. Characterization of human cystathionine β-synthase. Evidence for the identity of human L-serine dehydratase and cystathionine β-synthase. Biochim Biophys Acta 1974; 364: 128-139.
6. Stipanuk MH, Beck PW. Characterization of the enzymic capacity for cysteine desulphydration in liver and kidney of the rat. Biochem J 1982; 206: 267-277.
7. Giulidori P, Galli-Kienle M, Catto E, Stramentinoli G. Transmethylation, transsulfuration, aminopropylation reaction of S-adenolsyl-L-methionine in vivo. J Biol Chem 1984; 259: 4205-4211.
8. 35S]Thiosulphate oxidation by rat liver mitochondria in the presence of glutathione. Biochem J 1967; 103: 791-795.
9. Kun E, Fanshier DW. Isolation and properties of a β-mercaptopyruvate-cleaving copper enzyme. Biochem Biophys Acta 1959; 32: 338-348.
10. Reiffenstein RJ, Hulbert WC, Roth SH. Toxicology of hydrogen sulfide. Ann Rev Pharmacol Toxicol 1992; 32: 109-134.
11. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996; 16: 1066-1071.
12. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as a smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237: 527-531.
13. Grossman A, Costa A, Forsling ML, Jacobs R, Kostoglou-Athanassiou I, Nappi G, Navarra P, Satta M. Gaseous neurotransmitters in the hypothalamus. The roles of nitric oxide and carbon monoxide in neuroendocrinology. Horm Metabol Res 1997; 29: 477-482.
14. Kohl RL, Quay WB. Cystathionine synthase in rat brain: regional and time-of-day differences and their metabolic implications. J Neurosci Res 1979; 4: 189-196.
15. Heinonen K. Studies on cystathionase activity in rat liver and brain during development. Biochem J 1973; 136: 1011-1015.
16. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB. Interleukins-1 and 6 stimulate the release of corticotropin-releasing-hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclo-oxygenase pathway. Endocrinology 1991; 128: 37-44.
17. Stramentinoli G, Catto E, Algeri S. The increase in S-adenosyl-L-methionine (SAMc) concentrations in rat brain after its systemic administration. Comm Psychopharmacol 1977; 1: 89-97.
18. Navarra P, del Carmine R, Ciabattoni G, D'Amato M, Ragazzoni E, Vacca M, Volpe AR, Preziosi P. Hydroxyurea: relationship between toxicity and centrally-induced adrenal activation. Pharmacol Toxicol 1990; 67: 209-215.
19. Mancuso C, Ragazzoni E, Tringali G, Liberale I, Preziosi P, Grossman A, Navarra P. Inhibition of heme oxygenase in the central nervous system potentiates endotoxin-induced vasopressin release in the rat. J Neuroimmunol 1999; 99: 189-194.
20. Acevedo CH, Ahmed A. Heme oxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy. J Clin Invest 1998; 101: 949-955.
21. Nichol AW, Hendry I, Morell DB, Cłezy PS. Mechanism of formation of sulphhaemoglobin. Biochim Biophys Acta 1968; 156: 97-108.
22. Beauchamp RO, Bus JS, Popp JA, Boreiko CJ, Andjelkovich DA. A critical review of the literature on hydrogen sulfide toxicity. CRC Crit Rev Toxicol 1984; 13: 25-97.
23. Puka-Sundall M, Eriksson P, Nilsson M, Sandberg M, Lehamann A. Neurotoxicity of cysteine; interaction with glutamate. Brain Res 1995; 705: 65-70.
24. Cantoni GL, Mudd SH, Andreoli V. Affective disorders and S-adenosylmethionine: a new hypothesis. Trends Neurosci 1989; 12: 319-324.
25. Calogero AE, Gallucci WT, Chrousos GP, Gold PW. Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. J Clin Invest 1988; 82: 839-846.
26. Bottiglieri T, Laundy M, Martin R, Carney MWP, Nissenbaum H, Toone BK, Johnson AL, Reynolds EH. S-Adenosylmethionine influences monoamine metabolism. Lancet 1984; 28: 224.
27. Tsagarakis S, Holly JMP, Rees LH, Besser GM, Grossman A. Acetylcholine and norepinephrine stimulate the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro. Endocrinology 1988; 123: 1962-1969.
28. Stramentinoli G. Pharmacological aspects of S-adenosyl-methionine: pharmacokinetics and pharmacodynamics. Am J Med 1987; 83: 35-42.
29. Mato JM, Alvarez L, Ortiz P, Pajares MA. S-Adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther 1997; 73: 265-280.
30. Gharib A, Sarda N, Chabannes B, Cronenberg L, Pacheco H. The regional concentrations of S-adenosyl-L-methionine, S-adenosyl-L-homocysteine, and adenosine in rat brain. J Neurochem 1982; 38: 810-815.
31. Gil B, Pajares MA, Mato JM, Alvarez L. Glucocorticoid regulation of hepatic S-adenosylmethionine synthetase gene expression. Endocrinology 1997; 138: 1251-1258.
32. John RA, Charteris A, Fowler LJ. The reaction of amino-oxyacetate with pyridoxal phosphate-dependent enzymes. Biochem J 1978; 171: 771-779.
33. Alston TA, Porter DJT, Mela L, Bright HJ. Inactivation of alanine aminotransferase by the neurotoxin β-cyano-L-alanine. Biochem Biophys Res Commun 1980; 92: 299-304.
34. Roy DN, Sabri MI, Kayton RJ, Spencer PS. Beta-cyano-L-alanine toxicity: evidence for the involvement of excitotoxic mechanism. Nat Toxins 1996; 4: 247-253.
35. McMaster OG, Du F, French ED, Schwarcz R. Focal injection of aminooxyacetic acid produces seizures and lesions in rat hippocampus: evidence for mediation by NMDA receptors. Exp Neurol 1991; 113: 378-385.
36. Kombian SB, Reiffenstein RJ, Colmers WF. The actions of hydrogen sulfide on dorsal raphe serotonergic neurons in vitro. J Neurophysiol 1993; 70: 81-96.
37. 2+ involvement. Immunopharmacol Immunotoxicol 1997; 19: 393-404.
38. Bottiglieri T, Hyland K. S-adenosylmethionine levels in psychiatric and neurological disorders: a review. Acta Neurol Scand Suppl 1994; 154: 19-26.
39. Baldessarini RJ. Neuropharmacology of S-adenosyl-L-methionine. Am J Med 1987; 83: 95-103.
40. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999; 160: 1-12.